Chemical Structure (Propranolol 01)
Propranolol Hydrochloride Capsule, Extended Release
Product Images NDC 51991-820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propranolol Hydrochloride (NDC 51991-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (60 mg Capsule Bottle Label)
This is a description of Propranolol Hydrochloride Extended-Release Capsules, USP. It contains 60mg of Popranoll ytrochoride and should be stored at a temperature range of 20°-25°C (66°-77°F), with excursions permitted between 15°-30°C (59°-86°F). The capsules come in a light-resistant container as defined in the USP, and precautions should be taken to protect the capsules from light, moisture, excessive heat, and freezing. The NDĆ number is 51991-817-01, and the capsules are Rx only. They are manufactured by Adore Pharmaceuticals Inc. and distributed by Bredeenridge Pharmaceutica Inc. in Berlin, USA.*
Principal Display Panel (80 mg Capsule Bottle Label)
This is a description of a medication called Propranolol Hydrochloride Extended-Release Capsules, USP, containing 80mg of propranolol hydrochloride. The medication is stored at a temperature range of 20-25°C (68-77°F), with allowed excursions of 15-30°C (59-86°F), and comes in a tightly sealed, light-resistant container as defined by USP regulations. The medication is distributed by Bredeenridge Pharmaceutica Inc. & Berlin, CT06037 and manufactured by Adore Pharmaceuticals Inc., Vandalig, OH 45377, USA. The medication label refers to the Diffucaps® drug delivery product, and the prescribing information is available as an insert. This medication is only available with a prescription.*
Principal Display Panel (120 mg Capsule Bottle Label)
Principal Display Panel (160 mg Capsule Bottle Label)
Propranolol Hydrochloride Extended-Release Capsules, USP is a medication containing 160 mg of propranolol hydrochloride, used for prescribing. It is recommended to store at or below 25°C in a light-resistant, moisture-free, and heat-protected container. The medication comes in 100 capsules packed in a USP-defined container. The NDC number is 51991-820-01. Manufactured by Adore Pharmaceutics Inc, Vandalia, OH, USA, it is distributed by Bredeenridge Pharmaceuticals Inc, Berlin, CT.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
